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Taxol and Taurine Protect the Renal Tissue of Rats after Unilateral 
Ureteral Obstruction: A Stereological Survey
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Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Purpose: Blockage of the urinary tract induces changes in renal structure including 
tubular dilatation or atrophy, tubular cell death, inflammatory processes, and pro-
gressive interstitial ﬁbrosis with the loss of renal parenchyma. The present study was 
conducted to survey the protective effects of Taxol and taurine on the renal structure 
after unilateral ureteral obstruction (UUO).
Materials and Methods: UUO was induced in three groups of rats (n=6) who then re-
ceived distilled water, Taxol (0.3 mg/kg/d), or taurine (7.5 mg/kg/d). Stereological meth-
ods were used to gather quantitative as well as comparative data. 
Results: Less than -8% of the volume of the glomeruli, proximal convoluted tubules 
(PCT), distal convoluted tubules (DCT), Henle’s loop, and collecting ducts were pre-
served after UUO. After treatment of the UUO rats with Taxol, between -32% and 88% 
of the parameters mentioned above remained intact, and after treatment of the UUO 
rats with taurine, between -16% and 46% of the parameters remained intact (p＜0.01). 
Compared with the untreated UUO animals, the volume of necrotic and fibrotic tissues 
decreased -53% and -63% in the UUO rats treated with Taxol and taurine, respectively 
(p＜0.01). Less than -3% of the lengths of the renal tubules (PCT, DCT, Henle’s loop, 
and collecting) were preserved in the UUO rats. After treatment with Taxol and taurine, 
-61% to 70% and -43% to 53% of the length of the renal tubules were preserved, re-
spectively (p＜0.01). 
Conclusions: Taurine and Taxol are effective in preventing some structural renal dam-
age in a direct ureteral obstruction model. Taxol was more effective in renal protection.
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INTRODUCTION
Chronic kidney diseases, which lead to end-stage kidney 
failure, are associated with changes in kidney structure 
and fibrosis regardless of the underlying cause [1]. Urinary 
tract obstruction is characterized by tubular atrophy or di-
lation, tubular cell death by apoptosis and necrosis, inter-
stitial leukocyte infiltration, and increased interstitial ma-
trix deposition. [1]. Such an obstruction might be observed 
after benign prostatic hyperplasia; renal, ureteral, or blad-
der calculi; urethral stricture; and neoplasm of the bladder, 
prostate, or urethra [1]. The hydrostatic pressure, which 
is the result of the blockage, initiates renal injuries. The 
injuries are characterized by tubular dilatation or atrophy, 
inflammatory inﬁltration of leucocytes, fibroblast activa-
tion, proliferation, increase in matrix proteins, and pro-
gressive interstitial ﬁbrosis with the loss of renal 
parenchyma. Unilateral ureteral obstruction (UUO) is an 
experimental rat model of renal injury that imitates the 
process of obstructive nephropathy in an accelerated man-
ner [1]. Evidence supports a key role of the inflammatory 
process in the renal structural changes that occur after ur-
opathy [2].
Taurine (2-aminoethanesulfonic acid) is an organic acid 
and a major component of the bile. Taurine is a derivative 
of the sulfur-containing amino acid cysteine. Taurine has Korean J Urol 2012;53:360-367
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FIG. 1. Estimation of kidney volume by use of the immersion 
method. (A) A laboratory jar was filled with distilled water, was 
placed on the scale, and weighed. (B) The kidney was suspended 
by a thin thread in the laboratory jar. The kidney did not have to 
touch the bottom or sides of the jar. The new weight in grams 
minus the weight of the laboratory jar and water divided by the 
specific gravity of the distilled water (-1.0) was considered the 
primary volume of the kidney in cubic centimeters. 
been shown to have beneficial effects on the renal fibrosis 
that occurs after cisplatin-induced injuries, diabetic 
nephropathy, and age-related renal changes [1,3,4]. Tau-
rine has also been associated with a reduction in oxidant 
levels in diabetic nephropathy [4]. It also plays an im-
portant role in some biochemical and physiological proc-
esses in the kidney. In a review, Chesney et al. [2] described 
the renal-taurine interactions related to ion reabsorption, 
renal blood flow, renal vascular endothelial function, and 
antioxidant properties (especially in the glomerulus) [5]. 
In addition, it has been reported that taurine plays a major 
role in the renal cell cycle as well as in apoptosis and also 
functions as an osmolyte during the stress response. 
Taurine has been shown to play an important role in four 
different forms of kidney diseases: glomerulonephritis [6], 
diabetic nephropathy, chronic renal failure [7], and acute 
kidney injury [8]. 
Taxol (paclitaxel) is a mitotic inhibitor that is used in can-
cer chemotherapy. Paclitaxel stabilizes microtubules and 
as a result interferes with the normal breakdown of the mi-
crotubules during cell division. Sun et al. [9] and Zhang et 
al. [10] have reported that paclitaxel ameliorates fibrosis 
in the UUO rat kidney model. In addition, Sommardahl et 
al. [11] showed the efficacy of Taxol in the mouse model of 
polycystic kidney disease. In addition, Zhou et al. [12] re-
ported the ameliorative effects of paclitaxel on liver 
fibrosis. 
In this study, we tried to determine whether taurine and 
Taxol can attenuate the tubulointerstitial fibrosis and pre-
serve the normal renal histology in a rat model of UUO. 
Moreover, stereological survey was applied to investigate 
structural changes in the uropathic kidney, including the 
volume of the cortex, medulla, glomeruli, proximal con-
voluted tubules (PCT), distal convoluted tubules (DCT), 
Henle tubules, collecting ducts, vessels, and fibrous tissue. 
In addition, the length of the tubules and the vessels was 
estimated. These methods provide both quantitative and 
comparative data. 
MATERIALS AND METHODS
1. Animals
Twenty-four male rats weighing 160±30 g were selected. 
The animals were treated according to the standard direc-
tive as recommended and approved by the research author-
ities of Shiraz University of Medical Sciences. The rats 
were randomly divided into four groups each including six 
animals, which is considered acceptable for stereological 
studies [13]. In group one (sham-operated animals), lapa-
rotomy only was done without any procedures and the rats 
did not receive any treatments. On the other hand, groups 
two, three, and four underwent a surgery to induce UUO. 
The second group received distilled water by gavage. The 
third group received Taxol (0.3 mg/kg twice per week intra-
peritoneally) for 28 days [8]. Finally, the fourth group was 
treated with taurine (7.5 mg/kg/d) dissolved in a distilled 
water vehicle given by gavage for 28 days [9]. 
2. Surgical procedure
After the rats were anesthetized with ketamine/xylosine 
(25 mg/kg i.p. and 2.5 mg/kg i.p., respectively), the abdomi-
nal cavity was opened by an incision to reach the left ureter. 
A 3-0 silk ligature was tied around the ureter, after which 
the incision was closed. After 28 days, the rats' kidneys 
were removed. 
3. Stereological study
The renal pelvis was dissected out and the kidney was 
weighed. The primary volume of the kidney, Vprimary, was 
measured by using Sherle's immersion method [14]. A brief 
description is presented under Fig. 1. The kidney was fixed 
in neutral buffered formaldehyde for 1 week. Then, the tis-
sue shrinkage produced by fixation, processing, and stain-
ing was estimated. Estimation of the shrinkage and the 
length of the renal tubules as well as the vessels requires 
isotropic, uniform random sections [15-17]. These sections 
were obtained through the orientator method. A brief de-
scription is presented under Fig. 2. The estimated shrink-
age was also used to estimate the final volume of the kidney 
to avoid the consecutive sectioning that is required for the 
Cavalieri method. A description can be found under Fig. 3. 
After estimating the volume shrinkage [15-17], the final 
volume of the kidney (the reference space) was corrected 
by using the following formula:
Vfinal=Vprimaryx(1−volume shrinkage).
4. Estimation of the volume and length densities
Each sampled section was analyzed by using a video micro-
scopy system that was made up of a microscope (E-200, Korean J Urol 2012;53:360-367
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FIG. 2. Isotropic uniform random sectioning by use of the orientator method. (A) The kidney was cleaned. (B) It was placed on the circle 
such that each half of it was divided into 10 equal parts. A random number between 0 and 9 was selected. The kidney was sectioned 
into two parts at the direction of the selected number (here 4). (C) The cut surface of one part of the kidney was, then, placed on the 
0-0 direction of the second circle with 10 unequal divisions. The circle division was done according to the cosine of the angels. Then, 
another random number was selected and the second cut was done (here 1). The parts were sectioned into parallel slabs (D) The cut 
surface of the other part of the kidney was placed vertically on the second circle. Again, a new number and direction (here 6) was 
selected and cut. This part was also sectioned into parallel slabs. 
FIG. 3. Estimation of shrinkage and slide preparation. (A) The entire kidney was sectioned into slabs with a blade and was placed in 
the direction of the isotropic uniform random cut with an interval of -0.5 mm. Then, the slabs (8 to 12 slabs) were collected. A circle 
(left arrow) was punched from a kidney slab (right arrow) by a trocar. The diameter of the circular piece and the area of the circle were 
estimated using the usual formula for calculating the area of a circle. (B) The cut surface of the slabs and the circle were embedded 
in the paraffin block. (C) Sectioning of the block using the microtome blade (5 μm thicknesses) is demonstrated. After staining with 
Heidenhain’s Azan trichrome, the area of the circular piece was measured again and the volume shrinkage was calculated by using 
the following formula: volume shrinkage:=1-(AA/AB)
1.5 where AA and AB, respectively ,represent the area of the circular piece after 
and before the processing, the sectioning, and the staining. After estimating the shrinkage, the final volume of the kidney (the 
reference space) was computed by using the following formula: Vfinal:=Vprimaryx(1−volume shrinkage). (D) The microscopic fields were 
sampled in a systematic random design. The fields were sampled and analyzed at equal intervals along the X- and Y-axis by using 
a stage micrometer. This procedure was continued until all the sections had been studied.
Nikon, Tokyo, Japan) linked to a video camera, a computer, 
and a monitor to determine the parameters. Between 8 and 
12 microscopic fields were selected in a systematic random 
manner. A description can be found under Fig. 3. Then, the 
stereological grids were superimposed on the images by 
means of the stereology software designed at Histomorpho-
metry & Stereological Research Center, Shiraz University 
of Medical Sciences, Shiraz, Iran.
The volume density of each structure (the fraction of the 
unit volume of the kidney that is occupied by the structure) 
was estimated by using the point-counting method. A brief 
description is presented under Fig. 4. The volume fraction 
of the cortex and the medulla were estimated at a final mag-
nification of x375 and other parameters at x1,500. The 
length density (the length of each tubular structure in the 
unit volume of the kidney) of the proximal and the DCT, 
collecting ducts, Henle’s loop, and vessels was estimated 
by randomly overlaying an unbiased counting frame [15] 
with an area of 2,700 μm
2 on the live monitor images. A brief 
description is presented as the legend of Fig. 5. 
Finally, the total volume of the parameters and the total 
length of the tubules as well as the vessels were estimated 
by multiplying the fractional volume or the length density 
by the final volume of the kidney to prevent the “reference 
trap” [15-17].
5. Statistical analysis
The data are reported as means and Standard deviations. 
Statistical comparisons between the group means were 
done by Kruskall-Wallis and Mann-Whitney U-test. Korean J Urol 2012;53:360-367
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FIG. 4. The volume density estimation using the point-counting 
method. A gird of points was superimposed upon the images of 
the renal sections were viewed on the monitor. The volume 
density (fractional volume) (Vv) of the renal cortex, the medulla, 
the glomeruli, the proximal convoluted tubules, the distal 
convoluted tubule, the collecting ducts, the Henle's loop, the 
vessels, and the connective tissue was obtained by using the 
point-counting method and the following formula: Vv=P(structure)/ 
P(total) where P(structure) and P(total) represent the sum of the number 
of the points hitting the structure and all sampled fields of the 
kidney, respectively. The point is the right upper corner of the 
cross (the arrow) (Heidenhain's AZAN trichrome stain, x200).
FIG. 5. The length density estimation in a kidney with an 
obstructed ureter. The counting frame with exclusion lines (bold 
lines of the left and lower borders) and inclusion lines (thin lines 
of the right and upper borders) was superimposed on the images. 
The tubules that were either completely or partly inside the 
counting frame and did not touch the exclusion lines were 
counted. The length density (Lv) of each tubule was calculated by 
using the following formula: Lv:=2x∑Q/∑AT where ΣQ denotes 
the total number of each tubule profiles counted per kidney and 
AT was the test area that was calculated by multiplying the area 
of the frame (here was 2,700 μm
2) and the total number of the 
counted frames (Heidenhain's AZAN trichrome stain, x400).
Moreover, p≤0.01 was considered as statistically 
significant.
RESULTS
1. Histopathological changes
The histological changes of the kidney after the UUO proce-
dure as well as after the UUO procedure plus Taxol or taur-
ine treatment can be observed in Fig. 6. Renal disruption, 
tubular atrophy, degeneration, necrosis, and fibrosis were 
observed in the UUO animals. After treatment with Taxol 
or taurine, the histopathological changes were amelio-
rated such that more tubules remained identifiable. The 
amount of fibrotic and necrotic tissue decreased after treat-
ment with Taxol or taurine. Furthermore, the UUO rats 
treated with Taxol showed more intact renal structures. 
2. Volume of the kidney structures
The mean and the standard deviation of the kidney volume, 
the volume of the cortex, and the volume of the medulla are 
presented in Table 1. No significant differences were ob-
served between the groups.
The total volume of the glomeruli, PCT, DCT, Henle’s 
loop, collecting duct, degenerative tubules, and necrotic 
and fibrotic tissue in the different groups is shown in Table 
2. The volume of the glomeruli, PCT, DCT, Henle’s loop, and 
collecting ducts was reduced in the rats after UUO. Less 
than -8% of these structures remained intact on average. 
After treatment of the UUO rats with Taxol, -87%, -32%, 
-51% , -72%, and -88% of the glomeruli, PCT, DCT, Henle’s 
loop, and collecting ducts remained intact, respectively (p
＜0.01). 
After treatment of the UUO rats with taurine, -25%, 
-16%, -16%, -40%, and -46% of the glomeruli, PCT, DCT, 
Henle’s loop, and collecting ducts remained intact, re-
spectively (p＜0.01). 
Table 2 depicts the increase in degenerative tubules and 
necrotic and fibrotic tissues in the UUO groups. In addi-
tion, after treating the UUO animals with Taxol, the vol-
ume of the degenerative tubules and necrotic and fibrotic 
tissues was decreased -42% and -53%, respectively, com-
pared with that in the UUO rats. 
After treating the UUO rats with taurine, the volume of 
the degenerative tubules increased 1.8-fold, whereas ne-
crotic and fibrotic tissues decreased -63% compared with 
that in the UUO rats without any treatments (p＜0.01).
3. Length of the tubular structures of the kidney
On average, less than -3% of the lengths of these structures 
remained intact in the UUO rats. After treatment of the 
UUO rats with Taxol, -65%, 70%, 56%, and 61% of the PCT, 
DCT, Henle’s loop, and collecting ducts remained intact, re-
spectively (p＜0.01). 
On the other hand, after treatment of the UUO rats with 
taurine, -49%, -53%, -43%, and -45%, of the length of the 
PCT, DCT, Henle’s loop, and collecting ducts remained in-Korean J Urol 2012;53:360-367
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FIG. 6. A comparison of the renal tissue in different groups. (A) The normal tissue. (B) The renal tissue after the unilateral ureteral 
obstruction (UUO). (C) The renal tissue after the UUO+taxol. (D) The renal tissue after the UUO+taurine (Heidenhain's AZAN 
trichrome stain, x200).
TABLE 1. Comparison of weight and volume among the groups
Group No. of rats
Animal weight 
(g)
Kidney weight 
(mg)
Kidney volume 
(mm
3)
Cortex volume 
(mm
3)
Medulla volume 
(mm
3)
1
a
2
b
3
c
4
d
6
6
6
6
180±16
169±13
165±13
163±9
536±42
538±63
  598±104
484±47
352±40
336±23
320±45
302±53
196±30
181±18
166±26
159±26
155±14
152±15
153±20
142±27
Values are presented as mean±standard deviation.
a: Sham-operated animals in which laparotomy was done without any procedure and no treatment was given, 
b: animals underwent 
a surgery to induce unilateral uretral obstruction, 
c: animals underwent a surgery to induce unilateral ureteral obstruction and received 
taxol (0.3 mg/kg twice per week intraperitoneally) for 28 days, 
d: animals underwent a surgery to induce unilateral ureteral obstruction
and received taurine (7.5 mg/kg/d) given by the gavage for 28 days.
tact, respectively (p＜0.01) (Table 3). 
DISCUSSION
The present study confirmed through a quantitative sur-
vey the protective role of Taxol and taurine on renal tissue 
damage after the induction of UUO in rats. Furthermore, 
the findings of the present study revealed that Taxol was 
more protective than taurine. Paclitaxel is an alkaloid 
plant that is derived from the bark of the Pacific yew tree. Korean J Urol 2012;53:360-367
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TABLE 2. Comparison of the volume of the renal structures in the groups
Group
No. of 
rats
Glomeruli 
(mm
3)
PCT 
(mm
3)
DCT 
(mm
3)
Henle’s loop 
(mm
3)
Collecting 
ducts (mm
3)
Degenerative 
tubules (mm
3)
Necrotic & 
fibrotic 
tissues (mm
3)
1
a
2
b
3
c
4
d
6
6
6
6
16±6
  1±1
e
14±7
f
  4±3
192±37
    1±1
e
  63±18
f
  32±5
43±9
  1±1
e
22±3
f
  7±6
25±12
  1±1
e
18±6
10±7
26±7
  2±2
e
23±4
f
12±4
  1±1
21±7
e
  9±9
f
37±12
    1±1
309±23
e
165±24
f
197±42
Values are presented as mean±standard deviation.
PCT, proximal convoluted tubule; DCT, distal convoluted tubule.
a: Sham-operated animals in which laparotomy was done without any procedure and no treatment was given, 
b: animals underwent 
a surgery to induce unilateral uretral obstruction, 
c: animals underwent a surgery to induce unilateral ureteral obstruction and received
taxol (0.3 mg/kg twice per week intraperitoneally) for 28 days, 
d: animals underwent a surgery to induce unilateral ureteral obstruction 
and received taurine (7.5 mg/kg/d) given by gavage for 28 days, 
e: p＜0.01, group 2 vs. (group 3) or (group 4), 
f: p＜0.01, (group 3) vs. 
(group 4).
TABLE 3. Comparison of the length of renal tubular structures in the groups
Group No. of rats
Proximal distal 
convoluted tubules (m)
 DCT 
(m)
Henle’s loop 
(m)
Collecting duct 
(m)  
Vessels 
(m)
1
a
2
b
3
c
4
d
6
6
6
6
87±3
  1±1
e
57±11
f
43±7
64±9
  1±1
e
45±9
f
34±6
39±9
  1±1
e
22±4
f
17±3
55±5
  1±1
e
34±6
 f
25±4
44±1
  1±1
e
17±6
14±3
Values are presented as mean±standard deviation.
PCT, proximalconvoluted tubule; DCT, distal convoluted tubule.
a: Sham-operated animals in which laparotomy was done without any procedure and no treatment was given, 
b: animals underwent 
a surgery to induce unilateral uretral obstruction, 
c: animals underwent a surgery to induce unilateral ureteral obstruction and received
taxol (0.3 mg/kg twice per week intraperitoneally) for 28 days, 
d: animals underwent a surgery to induce unilateral ureteral obstruction 
and received taurine (7.5 mg/kg/d) given by gavage for 28 days, 
e: p＜0.01, group 2 vs. (group 3) or (group 4), 
f:p＜0.01, (group 3) vs. 
(group 4).
Paclitaxel works by disrupting the microtubular network 
essential for cell division and other normal cellular func-
tions, which eventually leads to cell death [12]. The positive 
effects of Taxol have been reported in cisplatin-induced and 
ischemia-reperfusion injuries [18,19]. Moreover, a study 
demonstrated that Taxol can attenuate oxidative/nitro-
sative stress, glutathione depletion, enhanced urinary hy-
drogen peroxide excretion, and the decrease in antioxidant 
enzymes (catalase, glutathione peroxidase, and gluta-
thione-S-transferase) [18]. In addition, Yoon et al. [18] re-
ported that Taxol can induce cytoprotective enzymes and 
thereby improve the ischemia-reperfusion-induced changes 
in lipid hydroperoxides, glutathione, creatinine clearance, 
kidney weight, and histological abnormalities. 
The other compound that was used in the present study 
was taurine. The protective effect of taurine on nephrotox-
icity after cyclosporine or cisplatin treatment has been 
reported. It is believed that taurine, owing to its anti-
oxidant properties, avoids cyclosporine-induced reactive 
oxygen species and, consequently, nephrotoxicity [20,21]. 
In a recent article by Yousef et al. [22], it was shown that 
taurine induces a protective property after paraceta-
mol-induced oxidative injury of the kidney. Articles have 
discussed various mechanisms by which Taxol and taurine 
may protect renal structure changes after UUO. For exam-
ple, the results of a study by Sun et al. [9] revealed that a 
low dose of paclitaxel ameliorates renal fibrosis via the 
modulation of microRNA-192 pathobiology and trans-
forming growth factor-β signaling [10]. Transforming 
growth factor-β has been shown to play a central role in the 
development of the tubulointerstitial fibrosis. Guerrero- 
Beltran et al. [23] reported that Taxol can prevent cell 
death and inflammation in nephropathy. The antifibrotic 
effects of Taxol have been observed in other tissues includ-
ing the liver. The findings of the study by Zhou et al. [12] 
indicate that 200 nmol/l paclitaxel ameliorates hepatic fib-
rosis by modulating transforming growth factor-beta 
signaling. In addition, Koz et al. [24] showed that paclitaxel 
provided antifibrotic effects during conjunctival wound 
healing. 
The role of taurine in various renal structures has also 
been reviewed [2]. These major roles include regulating the 
blood flow in the vasculature of the kidney, scavenging the 
reactive oxygen species in glomerulus, Na
+ transport in the 
proximal tubules, and osmoregulation as well as cell vol-
ume regulation in the medulla. In addition to the pre-Korean J Urol 2012;53:360-367
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ventive roles of taurine in renal fibrosis, other tissues can 
also be protected. Devi et al. [25] reported that taurine re-
duces iron-potentiated alcoholic liver fibrosis by reducing 
oxidative stress, inflammatory and fibrogenic mediators, 
and stellate cell activation. In addition, the results of the 
study by Devi and Anuradha [26] showed that the restora-
tive effect of taurine in an experimental model of liver fib-
rosis involved amelioration of protein and lipid damage by 
decreasing oxidative and nitrosative stresses. Therefore, 
a variety of mechanisms can be considered responsible for 
the protective effects of Taxol and taurine in the present 
study.
CONCLUSIONS
It can be concluded that Taxol and taurine are both effective 
in preventing some structural renal damage in the direct 
obstruction model in rats. The volume of the necrotic and 
fibrotic tissue was found to be less in the Taxol- and taur-
ine-treated groups. Furthermore, taurine revealed a more 
protective role on renal structures.
CONFLICTS OF INTEREST
The authors have nothing to disclose.
ACKNOWLEDGEMENTS
The present research was carried out at the Histomorpho-
metry & Stereology Research Center of Shiraz University 
of Medical Sciences. The authors would like to thank Dr. 
Ali Musavi as well as Mr. Hashem Zare as the software 
providers. They also would like to thank Miss. Elham Nadi-
mi, Miss. Zahra Keshavarz, and Mr. Mehrdad Azadi for 
their technical assistance. The Research Improvement 
Center of Shiraz University of Medical Sciences and Ms. 
Afsaneh Keivanshekouh are also appreciated for improv-
ing the use of English in the manuscript.
REFERENCES 
1. Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M. 
Protective effect of taurine against renal interstitial fibrosis of 
rats induced by cisplatin. Naunyn Schmiedebergs Arch Pharma-
col 2002;365:277-83. 
2. Chesney RW, Han X, Patters AB. Taurine and the renal system. 
J Biomed Sci 2010;17 Suppl 1:S4.
3. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, 
Fuchs A, et al. Taurine ameliorates chronic streptozocin-induced 
diabetic nephropathy in rats. Am J Physiol 1995;269(3 Pt 
2):F429-38.
4. Cruz CI, Ruiz-Torres P, del Moral RG, Rodriguez-Puyol M, 
Rodríguez-Puyol D. Age-related progressive renal fibrosis in rats 
and its prevention with ACE inhibitors and taurine. Am J Physiol 
Renal Physiol 2000;278:F122-9.
5. Marcinkiewicz J, Kurnyta M, Biedron R, Bobek M, Kontny E, 
Maślinski W. Anti-inflammatory effects of taurine derivatives 
(taurine chloramine, taurine bromamine, and taurolidine) are 
mediated by different mechanisms. Adv Exp Med Biol 2006;583: 
481-92.
6. Odobasic D, Kitching AR, Semple TJ, Holdsworth SR. Endoge-
nous myeloperoxidase promotes neutrophil-mediated renal in-
jury, but attenuates T cell immunity inducing crescentic glomeru-
lonephritis. J Am Soc Nephrol 2007;18:760-70.
7. Suliman ME, Barany P, Filho JC, Lindholm B, Bergstrom J. 
Accumulation of taurine in patients with renal failure. Nephrol 
Dial Transplant 2002;17:528-9.
8. Erdem A, Gundogan NU, Usubutun A, Kilinç K, Erdem SR, Kara 
A, et al. The protective effect of taurine against gentamicin-in-
duced acute tubular necrosis in rats. Nephrol Dial Transplant 
2000;15:1175-82.
9. Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L, et al. Low-dose 
paclitaxel ameliorates fibrosis in the remnant kidney model by 
down-regulating miR-192. J Pathol 2011;225:364-77.
10. Zhang D, Sun L, Xian W, Liu F, Ling G, Xiao L, et al. Low-dose 
paclitaxel ameliorates renal fibrosis in rat UUO model by in-
hibition of TGF-beta/Smad activity. Lab Invest 2010;90:436-47.
11. Sommardahl CS, Woychik RP, Sweeney WE, Avner ED, 
Wilkinson JE. Efficacy of taxol in the orpk mouse model of poly-
cystic kidney disease. Pediatr Nephrol 1997;11:728-33.
12. Zhou J, Zhong DW, Wang QW, Miao XY, Xu XD. Paclitaxel amelio-
rates fibrosis in hepatic stellate cells via inhibition of TGF-be-
ta/Smad activity. World J Gastroenterol 2010;16:3330-4.
13. Hyde DM, Tyler NK, Plopper CG. Morphometry of the respiratory 
tract: avoiding the sampling, size, orientation, and reference 
traps. Toxicol Pathol 2007;35:41-8.
14. Scherle W. A simple method for volumetry of organs in quantita-
tive stereology. Mikroskopie 1970;26:57-60.
15. Nyengaard JR. Stereologic methods and their application in kid-
ney research. J Am Soc Nephrol 1999;10:1100-23.
16. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, 
Nielsen K, et al. Some new, simple and efficient stereological 
methods and their use in pathological research and diagnosis. 
APMIS 1988;96:379-94.
17. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, 
Marcussen N, et al. The new stereological tools: disector, fractio-
nator, nucleator and point sampled intercepts and their use in 
pathological research and diagnosis. APMIS 1988;96:857-81.
18. Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, Park BH. 
Sulforaphane protects kidneys against ischemia-reperfusion in-
jury through induction of the Nrf2-dependent phase 2 enzyme. 
Biochem Pharmacol 2008;75:2214-23.
19. Guerrero-Beltran CE, Calderon-Oliver M, Tapia E, Medina- 
Campos ON, Sanchez-Gonzalez DJ, Martínez-Martinez CM, et 
al. Sulforaphane protects against cisplatin-induced nephroto-
xicity. Toxicol Lett 2010;192:278-85.
20. Mostafavi-Pour Z, Zal F, Monabati A, Vessal M. Protective effects 
of a combination of quercetin and vitamin E against cyclosporine 
A-induced oxidative stress and hepatotoxicity in rats. Hepatol 
Res 2008;38:385-92.
21. Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal 
F, Morales AI, Lopez-Novoa JM. Quercetin reduces cisplatin 
nephrotoxicity in rats without compromising its anti-tumour 
activity. Nephrol Dial Transplant 2011;26:3484-95.
22. Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. Potential 
protective effects of quercetin and curcumin on paracetamol-in-
duced histological changes, oxidative stress, impaired liver and 
kidney functions and haematotoxicity in rat. Food Chem Toxicol 
2010;48:3246-61.
23. Guerrero-Beltran CE, Mukhopadhyay P, Horvath B, Rajesh M, 
Tapia E, Garcia-Torres I, et al. Sulforaphane, a natural con-
stituent of broccoli, prevents cell death and inflammation in Korean J Urol 2012;53:360-367
Effect of Taxol & Taurine on Renal Damage 367
nephropathy. J Nutr Biochem 2012;23:494-500.
24. Koz OG, Ozhuy S, Tezel GG, Karaman N, Unlu N, Yarangumeli 
A, et al. The effect of paclitaxel on conjunctival wound healing: 
a pilot study. J Glaucoma 2007;16:610-5.
25. Devi SL, Viswanathan P, Anuradha CV. Regression of liver fib-
rosis by taurine in rats fed alcohol: effects on collagen accumu-
lation, selected cytokines and stellate cell activation. Eur J 
Pharmacol 2010;647:161-70.
26. Devi SL, Anuradha CV. Oxidative and nitrosative stress in ex-
perimental rat liver fibrosis: Protective effect of taurine. Environ 
Toxicol Pharmacol 2010;29:104-10.